There could be a new way to diagnose brain tumors earlier.
Investigators assessed effects of TIB on cell number, migration, invasion, estrogen, and progesterone receptor activity and content.
A new study offers hope in predicting glioblastoma responses to chemotherapy, radiation, and combination therapy.
Dr. Rimas Lukas on Controlled Interleukin-12 Combined With a PD-1 Inhibitor in Recurrent Glioblastoma
Cancer Network spoke with Rimas V. Lukas, MD, of Northwestern University Feinberg School of Medicine, about the combination of controlled interleukin-12 with a PD-1 inhibitor in recurrent glioblastoma.
Cancer Network spoke with Dr. Shulin Li about his team’s research on the role of the FGL2 protein in glioblastoma immune evasion and tumor progression.
This review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.
Dr. James Perry speaks with Cancer Network about glioma therapy options and the future of brain cancer treatment.
New research published in Neuro-Oncology examines the controversial link between intracranial volume and high-grade glioma.
MRI-guided laser interstitial thermal therapy appears to be safe and effective for glioblastomas and may add an average of 2 months to life expectancy.
Researchers report that the same driving force that makes Zika so detrimental to unborn babies gives it promise as a cancer treatment.